Related Experiment Video
Updated: Jul 12, 2026

08:58
Enhanced Rabies Surveillance Using a Direct Rapid Immunohistochemical Test
Published on: April 30, 2019
Summary
Federal support for scientific data management is insufficient, hindering productivity and innovation. A national policy is proposed to prioritize making existing knowledge accessible for R&D and manufacturing.
Area of Science:
- Science and Technology Policy
- Data Management
- Research and Development
Background:
- Productivity growth rates are lagging, despite increased interest in research.
- Accurate and accessible data are crucial for R&D projects and advanced manufacturing.
- Current federal support for reviewing and packaging new knowledge is inadequate.
Purpose of the Study:
- To highlight the critical need for robust data management in science and technology.
- To propose a national science and technology data policy.
- To advocate for prioritizing the accessibility of existing knowledge.
Main Methods:
- Analysis of current trends in productivity and research support.
- Identification of the limitations of non-governmental entities in data management.
- Development of a proposed six-point national data policy.
Main Results:
- Federal support for scientific data review and packaging remains insufficient.
- Reliable and retrievable data are essential for scientific progress and industrial application.
- Existing knowledge accessibility is identified as a foundational element for overall science and technology advancement.
Conclusions:
- A comprehensive national science and technology policy is necessary.
- Prioritizing the availability of existing knowledge is the first step towards progress.
- Federal leadership is required to ensure effective data management and accessibility.
Related Concept Videos
Drug Regulation
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
Biopharmaceutical Factors Influencing Drug Product Design: Overview
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though pharmacologically...
Recombinant DNA
Overview
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
Drug Control Governance: Regulatory Bodies and Their Impact
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with a...
Bioreactor Controls-III
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...

